Novavax vaccine found to be 86% effective against UK Covid strain in late-stage trial
Novavax’s Covid-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.